Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$690K Buy
3,100
+311
+11% +$56.5K 0.03% 523
2026
Q1
$429K Buy
2,789
+418
+18% +$56.7K 0.02% 651
2025
Q4
$269K Buy
2,371
+881
+59% +$107K 0.01% 837
2025
Q3
$198K Buy
1,490
+43
+3% +$5.9K 0.01% 984
2025
Q2
$206K Sell
1,447
-88
-6% -$12.5K 0.01% 899
2025
Q1
$235K Sell
1,535
-52
-3% -$8.17K 0.02% 695
2024
Q4
$237K Buy
1,587
+272
+21% +$42.6K 0.02% 620
2024
Q3
$216K Buy
1,315
+240
+22% +$35.5K 0.02% 589
2024
Q2
$149K Buy
1,075
+418
+64% +$57.6K 0.02% 599
2024
Q1
$90.7K Buy
657
+104
+19% +$12.5K 0.02% 693
2023
Q4
$59.8K Buy
+553
New +$51.1K 0.02% 798

Other funds holding DVA

GAMMA Investing's DVA Position: Q2 2026 in Review

GAMMA Investing increased its DaVita (DVA) stake by 11% in Q2 2026, buying an estimated $56.5K and bringing the position to 3,100 shares worth $690K. The position accounts for 0.03% of the portfolio, ranked #523.

GAMMA Investing first reported a position in DVA in Q4 2023 and has held it in 11 quarters since. 87 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • GAMMA Investing held 3,100 shares of DaVita worth $690K as of Q2 2026.
  • GAMMA Investing bought 311 DaVita shares in Q2 2026, an estimated $56.5K.
  • DaVita made up 0.03% of GAMMA Investing's portfolio in Q2 2026, its #523 holding.
  • GAMMA Investing first reported a position in DaVita in Q4 2023 and has held it in 11 quarters since.
  • 87 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.